FILE PHOTO: Chinese fax manufacturer CanSino Biologics’ sign is pictured at its building in Tianjin, China November 20, 2018. REUTERS / Stringer / File Photo DUBAI (Reuters) – Saudi Arabia will soon begin Phase III clinical trials on about 5,000 people for a COVID-19 vaccine developed by China’s CanSino Biologics …
Read More »CanSino to launch Phase III trial of COVID-19 vaccine in Saudi Arabia
